Who to call at GSK plc, and when
Fundz watches for the moments GSK plc starts buying, and tells you who to reach.
- An alert the day GSK plc raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at GSK plc, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at GSK plc. With Fundz connected, it knows.
GSK Expands Partnership with CTTQ for China Commercialization Rights of Trelegy and Anoro Inhalers.
Contract Type
partnership
Description
GSK is expanding its partnership with Chia Tai Tianqing Pharmaceutical Group, granting them China commercialization rights for Trelegy Ellipta and Anoro Ellipta. This agreement enhances their previous collaboration by extending it into respiratory medicine, capitalizing on the large COPD and asthma patient market in China.
Quick answer
GSK Expands Partnership with CTTQ for China Commercialization Rights of Trelegy and Anoro Inhalers. (July 8, 2026).
- What agreement did GSK plc announce on July 8, 2026?
- GSK is expanding its partnership with Chia Tai Tianqing Pharmaceutical Group, granting them China commercialization rights for Trelegy Ellipta and Anoro Ellipta. This agreement enhances their previous collaboration by extending it into respiratory medicine, capitalizing on the large COPD and asthma patient market in China.
- What does GSK plc do?
- GSK plc is a global healthcare company that researches and develops innovative pharmaceutical products, including vaccines.
Source: Fundz verified event record.
Related People
Agreement Insights
What this usually meansGSK plc signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.